[Development of a biochip for quantitative determination of two forms of prostate specific antigen using internal calibration curve].
Three-dimensional gel-based microchip allowing simultaneous quantitative detection of total (PSAtot) and free (PSAfree) forms of prostate specific antigen in human serum (in a format "one patient-one biochip") was developed. A method, which doesn't require preliminary construction of calibration curves when performing an assay, was applied for quantitative determination of PSAtot and PSAfree. Gel elements with immobilized antigen (PSA) in different concentration, forming an internal calibration curve, were included in a structure of the microchip, in addition to the elements with immobilized antibodies specific against PSAtot and PSAfree. The specialized software "ImaGelAssay" was used for data processing and interpretation. The sensitivity of the assay performed on biochips was 0.3 ng/ml for PSAtot and 0.2 ng/ml for PSAfree. Variation coefficient for the measurements inside one series of microchips didn't exceed 10%. Correlation coefficient between the results of measurements in human sera obtained on biochips and by the standard ELISA method was 0.988 for PSAtot and 0.987 for PSAfree.
Konovalova
E V
EV
Savvateeva
E N
EN
Dement'eva
E I
EI
Filippova
M A
MA
Turygin
A Iu
AIu
Osipova
T V
TV
Riabykh
T P
TP
Rubina
A Iu
AIu
Zasedatelev
A S
AS
D014408:Biomarkers, Tumor / Q000097:blood*; D002138:Calibration; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D040081:Protein Array Analysis / Q000379:methods* / Q000592:standards*; D012680:Sensitivity and Specificity; D012984:Software
D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen